Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Multi Cap Fund median (29 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 13 Sep 2024 – 20 Aug 2026, limited by PGIM India Multi Cap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | PGIM India Multi Cap Fund | Nifty 500 |
|---|---|---|
| 13 Sep 2024 | ₹100.00 | ₹100.00 |
| 11 Nov 2024 | ₹93.86 | ₹94.41 |
| 09 Jan 2025 | ₹93.46 | ₹92.14 |
| 09 Mar 2025 | ₹85.13 | ₹85.44 |
| 06 May 2025 | ₹90.98 | ₹91.76 |
| 04 Jul 2025 | ₹98.81 | ₹98.47 |
| 01 Sep 2025 | ₹98.81 | ₹94.92 |
| 30 Oct 2025 | ₹102.87 | ₹99.64 |
| 28 Dec 2025 | ₹100.40 | ₹99.38 |
| 25 Feb 2026 | ₹99.80 | ₹97.81 |
| 24 Apr 2026 | ₹99.11 | ₹94.32 |
| 22 Jun 2026 | ₹105.15 | ₹97.22 |
| 20 Aug 2026 | ₹110.80 | ₹98.26 |
| Metric | PGIM India · Direct · IDCW NAV ₹11.18 Very High risk ★★★★☆ 1Y | Category median Multi Cap Fund · 29 funds |
|---|---|---|
| +10.80% | +6.55% | |
| — | +13.71% | |
| — | +12.07% | |
| — | +9.16% | |
| +5.45% | +14.55% | |
| +13.91% | — | |
| — | +17.33% | |
| — | +14.39% | |
| — | +9.74% | |
| Risk | ||
| 14.50% | 15.40% | |
| 0.30 | 0.41 | |
| 0.41 | 0.54 | |
| -18.10% | -21.00% | |
| Nifty 500 | — | |
| — | +1.30% | |
| — | 1.03 | |
| — | 104.7% | |
| — | 99.6% | |
| 0.85% | 0.93% | |
| ₹415.28Cr | ₹4,007Cr | |
| Up to 0.50% | — | |
| None | — | |
| ₹1.00K | — | |
| ₹5.00K | — | |
| 27% | 53% | |
| Padmanabhan Anjeneyan | — | |
| 13 Sep 2024 | — | |
| 95 | — | |
| 23.0% | — | |
| -0.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.